Fortress Biotech (FBIO) Total Non-Current Liabilities (2012 - 2026)
Fortress Biotech's Total Non-Current Liabilities was $108.09 million in Q2 2026, down 10.6% from $120.85 million a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Fortress Biotech came in at $121.92 million, down 15.4% from FY2024.
- Total Non-Current Liabilities has now declined for three consecutive years, with a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $144.11 million in FY2024 (-12.2%), $164.05 million in FY2023 (-32.3%), $242.43 million in FY2022 (+43.8%) and $168.59 million in FY2021 (+25.4%).
- The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q2 2017.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2021 (growth of 71.3%); the worst was Q4 2023 (a decline of 32.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Fortress Biotech | 72.28 Mn | -322.33 Mn | 12.58 Mn | 108.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.09 Mn |
| Dec 31, 2025 | 121.92 Mn |
| Sep 30, 2025 | 114.61 Mn |
| Jun 30, 2025 | 120.85 Mn |
| Mar 31, 2025 | 143.88 Mn |
| Dec 31, 2024 | 144.11 Mn |
| Sep 30, 2024 | 138.07 Mn |
| Jun 30, 2024 | 158.48 Mn |
| Mar 31, 2024 | 166.74 Mn |
| Dec 31, 2023 | 164.05 Mn |
| Sep 30, 2023 | 162.09 Mn |
| Jun 30, 2023 | 194.91 Mn |
| Mar 31, 2023 | 241.95 Mn |
| Dec 31, 2022 | 242.43 Mn |
| Sep 30, 2022 | 220.32 Mn |
| Jun 30, 2022 | 214.31 Mn |
| Mar 31, 2022 | 212.37 Mn |
| Dec 31, 2021 | 168.59 Mn |
| Sep 30, 2021 | 191.00 Mn |
| Jun 30, 2021 | 165.57 Mn |
API Access
Fortress Biotech Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();